Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice

Clicks: 253
ID: 268309
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
More stringent and mucosa-driven treatment targets as 'deep remission' and 'mucosal healing' have found traction in clinical practice. The most commonly used definition for MH in routine practice is endoscopic MAYO score
Reference Key
te2016journaltreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Römkens TE;Gijsbers K;Kievit W;Hoentjen F;Drenth JP;;
Journal Journal of gastrointestinal and liver diseases : JGLD
Year 2016
DOI
DOI not found
URL
https://www.pubmed.gov/27981302/
Keywords
Gastrointestinal National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult female male Remission Induction Colitis Ulcerative / drug therapy* Gastrointestinal Agents / therapeutic use* anti-inflammatory agents / therapeutic use* predictive value of tests netherlands crohn disease / drug therapy* endoscopy practice patterns intestinal mucosa / pathology health care surveys crohn disease / diagnosis wound healing / drug effects* intestinal mucosa / drug effects* pmid:27981302 doi:10.15403/jgld.2014.1121.254.ken tessa e h römkens kim gijsbers joost p h drenth ulcerative / diagnosis endpoint determination / trends gastroenterologists / trends* physicians' / trends*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.